This seems stupidly cheap.
- EBITDA at $1m per month. (in Jan)
- One-offs have passed (so we're told)
- Catalysts everywhere (earnings, divestments, acquisitions through big net cash/debt)
- $500k cost savings from one less license + required admin costs
Downsides are:
- Direct investment division keeps flailing (basically no EBITDA contribution, taking management time)
- SSI division may not fully recover revenues.
Ann: Business Update 2022 AGM, page-46
Add SEQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.005(1.49%) |
Mkt cap ! $40.96M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 34.5¢ | 32.0¢ | $364.3K | 1.103M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3075 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 35624 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SEQ (ASX) Chart |